Patents by Inventor Chris DE SAVI

Chris DE SAVI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of TNF-? activity
    Patent number: 12384808
    Abstract: Provided herein are inhibitors of TNF?, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the TNF? inhibitory compounds for the treatment of diseases or disorders.
    Type: Grant
    Filed: November 21, 2023
    Date of Patent: August 12, 2025
    Assignee: FORWARD THERAPEUTICS, INC.
    Inventors: Toufike Kanouni, Chris De Savi
  • IRAK degraders and uses thereof
    Patent number: 12091411
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: January 31, 2023
    Date of Patent: September 17, 2024
    Assignee: Kymera Therapeutics, Inc.
    Inventors: Nello Mainolfi, Chris De Savi, Matthew M. Weiss, Xiao Zhu, Xiaozhang Zheng, Bruce C. Follows
  • MODULATORS OF TNF-ALPHA ACTIVITY
    Publication number: 20240247014
    Abstract: Provided herein are inhibitors of TNF?, pharmaceutical compositions comprising the inhibitory compounds, and methods for using the TNF? inhibitory compounds for the treatment of diseases or disorders.
    Type: Application
    Filed: November 21, 2023
    Publication date: July 25, 2024
    Inventors: Toufike KANOUNI, Chris DE SAVI
  • IRAK DEGRADERS AND USES THEREOF
    Publication number: 20230365562
    Abstract: The present invention provides compounds, compositions thereof, and methods of using the same.
    Type: Application
    Filed: January 31, 2023
    Publication date: November 16, 2023
    Inventors: Nello MAINOLFI, Chris DE SAVI, Matthew M. WEISS, Xiao ZHU, Xiaozhang ZHENG, Bruce C. FOLLOWS
  • STAT3 DEGRADERS AND USES THEREOF
    Publication number: 20230212201
    Abstract: The present invention relates to STAT3 degraders, their liquid formulations, and methods of use thereof for treating cancer.
    Type: Application
    Filed: December 9, 2022
    Publication date: July 6, 2023
    Inventors: Chris DE SAVI, Chris HO